Joachim Springub

Randomized phase III study 306

Gregory L. Krauss, José M. Serratosa, Vicente Villanueva et al. · Neurology · 2012 · 429 citations

Medicine, Pharmacology, Pharmacotherapy +15

Characterizing absolute lymphocyte count profiles in dimethyl fumarate–treated patients with MS

Robert J. Fox, Andrew Chan, Ralf Gold et al. · Neurology Clinical Practice · 2016 · 104 citations · Full text

Life Sciences, Immunology, Pharmacology +14

The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

Felix Rosenow, Carmen Schade‐Brittinger, Nicole Burchardi et al. · Journal of Neurology Neurosurgery & Psychiatry · 2012 · 61 citations

Medicine, Pharmacology, Pharmacotherapy +14

Sleep and Quality of Life Under Prolonged Release Oxycodone/Naloxone for Severe Restless Legs Syndrome: An Analysis of Secondary Efficacy Variables of a Double-Blind, Randomized, Placebo-Controlled Study with an Open-Label Extension

Wolfgang H. Oertel, Yngve Hallström, G. Saletu‐Zyhlarz et al. · CNS Drugs · 2016 · 23 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Flexible dosing of adjunctive zonisamide in the treatment of adult partial-onset seizures: a non-comparative, open-label study (ZEUS)

S. Dupont, Salvatore Striano, Eugen Trinka et al. · Acta Neurologica Scandinavica · 2009 · 21 citations

Medicine, Pharmacology, Pharmacotherapy +14